Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
Abstract The Phase 3 randomized controlled trial, TBTC Study 31/ACTG A5349 (NCT02410772) demonstrated that a 4-month rifapentine-moxifloxacin regimen for drug-susceptible pulmonary tuberculosis was safe and effective. The primary efficacy outcome was 12-month tuberculosis disease free survival, whil...
| Published in: | Nature Communications |
|---|---|
| Main Authors: | Vincent K. Chang, Marjorie Z. Imperial, Patrick P. J. Phillips, Gustavo E. Velásquez, Payam Nahid, Andrew Vernon, Ekaterina V. Kurbatova, Susan Swindells, Richard E. Chaisson, Susan E. Dorman, John L. Johnson, Marc Weiner, Amina Jindani, Thomas Harrison, Erin E. Sizemore, William Whitworth, Wendy Carr, Kia E. Bryant, Deron Burton, Kelly E. Dooley, Melissa Engle, Pheona Nsubuga, Andreas H. Diacon, Nguyen Viet Nhung, Rodney Dawson, Radojka M. Savic, AIDS Clinical Trial Group, Tuberculosis Trials Consortium |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-10-01
|
| Online Access: | https://doi.org/10.1038/s41467-024-53273-7 |
Similar Items
Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
by: Vincent K. Chang, et al.
Published: (2025-05-01)
by: Vincent K. Chang, et al.
Published: (2025-05-01)
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes
by: Ekaterina V. Kurbatova, et al.
Published: (2025-03-01)
by: Ekaterina V. Kurbatova, et al.
Published: (2025-03-01)
A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis.
by: Marcus B Conde, et al.
Published: (2016-01-01)
by: Marcus B Conde, et al.
Published: (2016-01-01)
Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology.
by: Kelly E Dooley, et al.
Published: (2019-07-01)
by: Kelly E Dooley, et al.
Published: (2019-07-01)
Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites.
by: RTS,S Clinical Trials Partnership
Published: (2014-07-01)
by: RTS,S Clinical Trials Partnership
Published: (2014-07-01)
Impact of herbivore identity on algal succession and coral growth on a Caribbean reef.
by: Deron E Burkepile, et al.
Published: (2010-01-01)
by: Deron E Burkepile, et al.
Published: (2010-01-01)
FOREIGN PRACTICE OF ORGANIZATION OF CARGO TRANSPORTATION BY INLAND WATER TRANSPORT IN RIVERSIDE CITIES
by: E. Kurbatova
Published: (2018-07-01)
by: E. Kurbatova
Published: (2018-07-01)
Predictive value of TNF-α, IFN-γ, and IL-10 for tuberculosis among recently exposed contacts in the United States and Canada
by: Mary R. Reichler, et al.
Published: (2020-07-01)
by: Mary R. Reichler, et al.
Published: (2020-07-01)
A Case of Malaria Predisposing to Salmonella Bacteremia in a Returning Traveler from Nigeria
by: Robert Jakubowski, et al.
Published: (2018-01-01)
by: Robert Jakubowski, et al.
Published: (2018-01-01)
A Case of Peritoneal Tuberculosis Mimicking Ovarian Cancer in a Young Female
by: Oriel Nissim, et al.
Published: (2022-01-01)
by: Oriel Nissim, et al.
Published: (2022-01-01)
THE RAILWAY TO THE PACIFIC OCEAN (FOR THE 100-TH ANNIVERSARY OF THE TRANS-SIBERIAN RAILWAY)
by: V. Persianov, et al.
Published: (2017-03-01)
by: V. Persianov, et al.
Published: (2017-03-01)
THE RAILWAY TO THE PACIFIC OCEAN (FOR THE 100-TH ANNIVERSARY OF THE TRANS-SIBERIAN RAILWAY)
by: V. Persianov, et al.
Published: (2019-02-01)
by: V. Persianov, et al.
Published: (2019-02-01)
IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapy.
by: Barham K Abu Dayyeh, et al.
Published: (2011-01-01)
by: Barham K Abu Dayyeh, et al.
Published: (2011-01-01)
The history of the government regulation of inLAND waterways before revolution in Russia
by: T. Gaynochenko, et al.
Published: (2016-04-01)
by: T. Gaynochenko, et al.
Published: (2016-04-01)
Myxobacteria: Physiology and Regulation
by: David E. Whitworth
Published: (2022-04-01)
by: David E. Whitworth
Published: (2022-04-01)
The history of the government regulation of inLAND waterways before revolution in Russia
by: T. Gaynochenko, et al.
Published: (2019-02-01)
by: T. Gaynochenko, et al.
Published: (2019-02-01)
Characterizing spatial tuning functions of neurons in the auditory cortex of young and aged monkeys: A new perspective on old data.
by: James eEngle, et al.
Published: (2013-01-01)
by: James eEngle, et al.
Published: (2013-01-01)
Editorial: Mechanisms of Prokaryotic Predation
by: David E. Whitworth, et al.
Published: (2020-09-01)
by: David E. Whitworth, et al.
Published: (2020-09-01)
Rethinking latent TB? Think again
by: R.E. Chaisson, et al.
Published: (2024-08-01)
by: R.E. Chaisson, et al.
Published: (2024-08-01)
The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection
by: David W Dowdy, et al.
Published: (2009-04-01)
by: David W Dowdy, et al.
Published: (2009-04-01)
Author reply
by: David W Dowdy, et al.
Published: (2009-12-01)
by: David W Dowdy, et al.
Published: (2009-12-01)
Determinants of facilitated health insurance enrollment for patients with HIV disease, and impact of insurance enrollment on targeted health outcomes
by: Renae Furl, et al.
Published: (2018-03-01)
by: Renae Furl, et al.
Published: (2018-03-01)
Pharmacokinetic analysis across studies to drive knowledge‐integration: A tutorial on individual patient data meta‐analysis (IPDMA)
by: Rob C. vanWijk, et al.
Published: (2023-09-01)
by: Rob C. vanWijk, et al.
Published: (2023-09-01)
ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis
by: Linda J. Harrison, et al.
Published: (2025-08-01)
by: Linda J. Harrison, et al.
Published: (2025-08-01)
Vespucci: A Free, Cross-Platform Tool for Spectroscopic Data Analysis and Imaging
by: Daniel P. Foose, et al.
Published: (2016-01-01)
by: Daniel P. Foose, et al.
Published: (2016-01-01)
The formation of the methodology for the economic optimization of managerial decisions on transport
by: A. V. Kurbatova, et al.
Published: (2019-04-01)
by: A. V. Kurbatova, et al.
Published: (2019-04-01)
<title language="por">El acetaminofeno puede provocar asma
by: Erin E. Dooley
Published: (2010-04-01)
by: Erin E. Dooley
Published: (2010-04-01)
El latido
by: Erin E. Dooley
Published: (2010-10-01)
by: Erin E. Dooley
Published: (2010-10-01)
Primeros hallazgos del Estudio sobre hermanas
by: Erin E. Dooley
Published: (2009-08-01)
by: Erin E. Dooley
Published: (2009-08-01)
Dora Bruder and the Longue Durée
by: Susan Weiner
Published: (2007-06-01)
by: Susan Weiner
Published: (2007-06-01)
Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
by: Pobiner Bonnie F, et al.
Published: (2005-04-01)
by: Pobiner Bonnie F, et al.
Published: (2005-04-01)
Diagnostic accuracy of the NOVA Tuberculosis Total Antibody Rapid test for detection of pulmonary tuberculosis and infection with Mycobacterium tuberculosis
by: Gideon Nsubuga, et al.
Published: (2023-05-01)
by: Gideon Nsubuga, et al.
Published: (2023-05-01)
Dry January and beyond
by: eClinicalMedicine
Published: (2025-01-01)
by: eClinicalMedicine
Published: (2025-01-01)
A spotlight on maternal health
by: eClinicalMedicine
Published: (2024-01-01)
by: eClinicalMedicine
Published: (2024-01-01)
Gendered pain: a call for recognition and health equity
by: eClinicalMedicine
Published: (2024-03-01)
by: eClinicalMedicine
Published: (2024-03-01)
The two sides of opioids: The subtle boundary between medication and abuse
by: eClinicalMedicine
Published: (2022-06-01)
by: eClinicalMedicine
Published: (2022-06-01)
Psychedelic medicine and the clinical application of hallucinogens
by: eClinicalMedicine
Published: (2023-02-01)
by: eClinicalMedicine
Published: (2023-02-01)
Safeguarding early nutrition
by: eClinicalMedicine
Published: (2023-08-01)
by: eClinicalMedicine
Published: (2023-08-01)
Raising the voice for rare diseases: under the spotlight for equity
by: eClinicalMedicine
Published: (2023-03-01)
by: eClinicalMedicine
Published: (2023-03-01)
The current status of IVF: are we putting the needs of the individual first?
by: eClinicalMedicine
Published: (2023-11-01)
by: eClinicalMedicine
Published: (2023-11-01)
Similar Items
-
Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
by: Vincent K. Chang, et al.
Published: (2025-05-01) -
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes
by: Ekaterina V. Kurbatova, et al.
Published: (2025-03-01) -
A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis.
by: Marcus B Conde, et al.
Published: (2016-01-01) -
Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology.
by: Kelly E Dooley, et al.
Published: (2019-07-01) -
Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites.
by: RTS,S Clinical Trials Partnership
Published: (2014-07-01)
